查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
冠狀動脈支架的全球市場:規模，佔有率，趨勢(2023年～2029年):MedCore，各類型市場區隔(傳統金屬支架，藥物釋放型血管支架)
市場調查報告書
商品編碼
1306528

冠狀動脈支架的全球市場:規模，佔有率，趨勢(2023年～2029年):MedCore，各類型市場區隔(傳統金屬支架，藥物釋放型血管支架)

Coronary Stent Market Size, Share, Trends Analysis | Global | 2023 - 2029 | MedCore | Segmented by: Type (Bare-Metal Stents, Drug-Eluting Stents)
出版日期: | 出版商: iData Research Inc. | 英文 42 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2029 年，全球冠狀動脈支架市場將大幅增長至超過 48 億美元。波士頓科學公司、美敦力公司、雅培公司等已成為主要參與者，佔據了冠狀動脈支架全球大部分市場佔有率。

本報告提供全球冠狀動脈支架市場相關調查，提供市場概要，以及各市場區隔，各地區趨勢，競爭情形等資訊。

目錄

冠狀動脈支架市場

  • 摘要整理
    • 全球冠狀動脈支架市場概要
    • 競爭分析
    • 對像手術
    • 對像市場
    • 對像地區
  • 簡介
  • 手術數量
  • 市場概要
    • 各市場區隔
    • 各地區
  • 市場分析與預測
    • 冠狀動脈支架市場總合
    • 傳統金屬支架市場
    • 藥物釋放型血管支架市場
  • 促進因素與阻礙因素
    • 市場促進因素
    • 市場阻礙因素
  • 競爭市場佔有率分析
Product Code: iDATA_GLCS23

The global market size of coronary stents is projected to witness significant growth, exceeding $4.8 billion by 2029. Boston Scientific, Medtronic, and Abbott emerged as the key players dominating the majority of the global coronary stents market share. This comprehensive market research encompasses an in-depth analysis of coronary stents companies across over 70 countries worldwide.

CORONARY STENTS MARKET DATA INCLUDED:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Coronary Stents Procedure Volumes
  • Market Drivers & Limiters for Each Market Segment
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

CORONARY STENTS PROCEDURE VOLUMES

This study conducted by iData Research on the global coronary stents market includes an analysis of procedure volumes to enhance the accuracy of market sizing. The analysis provides detailed information on procedure volumes spanning a 10-year period and encompassing 70 countries. This comprehensive approach ensures a robust understanding of market dynamics and trends related to coronary stents.

CORONARY STENTS MARKET INSIGHTS

The Asia Pacific region emerged as the largest market for coronary stents, demonstrating substantial growth in unit sales. The growth of the coronary stent market in this region is closely linked to the annual volume of percutaneous coronary intervention (PCI) procedures. Any significant changes in the PCI procedure volume directly impact the sales volume of coronary stents. Furthermore, the implementation of systemic healthcare reforms, improved access to healthcare, and rising disposable income in the Asia Pacific region are anticipated to have a positive impact on the market for coronary stents. These factors collectively contribute to the growth and potential of the market in the region.

The global market size for coronary stents is projected to experience growth throughout the forecast period. The average selling price (ASP) within the coronary stent market is primarily influenced by the dominant drug-eluting stent (DES) segment, which constitutes a significant portion of the total units sold. Over the years, prices of DESs have substantially decreased since their initial introduction in 2003. This decline in prices can be attributed to factors such as unfavorable reimbursement conditions and intense competition within the market. However, moving forward, prices in the coronary stent market are expected to show growth. This increase in prices is driven by the prevailing trend of market consolidation. As the market undergoes consolidation, companies may have more control over pricing strategies, which can contribute to a rise in prices.

CORONARY STENTS MARKET SHARE INSIGHTS

In 2022, the global coronary stents market was dominated by three key competitors: Boston Scientific, Medtronic, and Abbott.

Boston Scientific emerged as the leading competitor in the global coronary stent market. The company's success can be largely attributed to its strong position in the drug-eluting stent (DES) market, where it held a significant market share. Boston Scientific offers several product lines, including the PREMIER™ and SYNERGY™ DES, as well as the REBEL™ bare-metal stent (BMS). Notably, the SYNERGY™ DES stands out as the first and only FDA-approved DES with an abluminal bioabsorbable polymer coating available in the U.S. market. The REBEL™ BMS, made of a platinum chromium alloy, is designed to reduce device usage, procedure times, and radiation exposure, providing additional benefits to physicians and patients.

RESEARCH REGIONAL COVERAGE

Throughout this comprehensive research series, iData Research has meticulously covered more than 70 countries worldwide, providing in-depth analysis and insights. Each global region is available as a stand-alone report, allowing you to tailor the data to your specific needs.

The regions covered in this series include:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Table of Contents

Coronary Stent Market

  • 6.1. Executive Summary
    • 6.1.1. Global Coronary Stent Market Overview
    • 6.1.2. Competitive Analysis
    • 6.1.3. Procedures Included
    • 6.1.4. Markets Included
    • 6.1.5. Regions Included
  • 6.2. Introduction
  • 6.3. Procedure Numbers
  • 6.4. Market Overview
    • 6.4.1. By Segment
    • 6.4.2. By Region
  • 6.5. Market Analysis and Forecast
    • 6.5.1. Total Coronary Stent Market
    • 6.5.2. Bare-Metal Stent Market
    • 6.5.3. Drug-Eluting Stent Market
  • 6.6. Drivers and Limiters
    • 6.6.1. Market Drivers
    • 6.6.2. Market Limiters
  • 6.7. Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 6-1: Coronary Stent Market, Global, 2022 & 2029 167
  • Chart 6-2: Angioplasty/PCI Procedures, Global, 2022 167
  • Chart 6-3: Angioplasty/PCI Procedures by Region, Global, 2019 - 2029 177
  • Chart 6-4: Coronary Stent Market by Segment, Global, 2019 - 2022 191
  • Chart 6-5: Coronary Stent Market by Region, Global, 2019 - 2029 193
  • Chart 6-6: Leading Competitors, Coronary Stent Market, Global, 2022 212

LIST OF FIGURES

  • Figure 6-1: Coronary Stent Procedures Covered 169
  • Figure 6-2: Coronary Stent Markets Covered 170
  • Figure 6-3: Coronary Stent Regions Covered, Global (1 of 2) 171
  • Figure 6-4: Coronary Stent Regions Covered, Global (2 of 2) 172
  • Figure 6-5: Total Angioplasty/PCI Procedures by Region, Global, 2019 - 2029 176
  • Figure 6-6: Angioplasty/PCI Procedures by Country, North America, 2019 - 2029 178
  • Figure 6-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 - 2029 (1 of 2) 179
  • Figure 6-8: Angioplasty/PCI Procedures by Country, Latin America, 2019 - 2029 (2 of 2) 180
  • Figure 6-9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 - 2029 181
  • Figure 6-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 - 2029 (1 of 2) 182
  • Figure 6-11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 - 2029 (2 of 2) 183
  • Figure 6-12: Angioplasty/PCI Procedures by Country, Middle East, 2019 - 2029 184
  • Figure 6-13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (1 of 3) 185
  • Figure 6-14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (2 of 3) 186
  • Figure 6-15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 - 2029 (3 of 3) 187
  • Figure 6-16: Angioplasty/PCI Procedures by Country, Africa, 2019 - 2029 188
  • Figure 6-17: Coronary Stent Market by Segment, Global, 2019 - 2029 (US$M) 190
  • Figure 6-18: Coronary Stent Market by Region, Global, 2019 - 2029 (US$M) 192
  • Figure 6-19: Total Coronary Stent Market, Global, 2019 - 2029 194
  • Figure 6-20: Units Sold by Region, Coronary Stent Market, Global, 2019 - 2029 195
  • Figure 6-21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 - 2029 (US$) 196
  • Figure 6-22: Market Value by Region, Coronary Stent Market, Global, 2019 - 2029 (US$M) 197
  • Figure 6-23: Bare-Metal Stent Market, Global, 2019 - 2029 198
  • Figure 6-24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 - 2029 199
  • Figure 6-25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 - 2029 (US$) 200
  • Figure 6-26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 - 2029 (US$M) 201
  • Figure 6-27: Drug-Eluting Stent Market, Global, 2019 - 2029 202
  • Figure 6-28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 - 2029 203
  • Figure 6-29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 - 2029 (US$) 204
  • Figure 6-30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 - 2029 (US$M) 205
  • Figure 6-31: Leading Competitors, Coronary Stent Market, Global, 2022 211